Browsing William Harvey Research Institute by Title
Now showing items 1977-1996 of 4694
-
Harmonisation of large-scale, heterogeneous individual participant adverse event data from randomised trials of statin therapy.
(SAGE Publications, 2022-07-09)BACKGROUND: Meta-analyses of individual-level data from randomised trials are often required to detect clinically worthwhile effects. The Cholesterol Treatment Trialists' Collaboration, which includes data from numerous ... -
Harmonizing and improving European education in prescribing: An overview of digital educational resources used in clinical pharmacology and therapeutics.
(2021-03)AIM: Improvement and harmonization of European clinical pharmacology and therapeutics (CPT) education is urgently required. Because digital educational resources can be easily shared, adapted to local situations and re-used ... -
Have the Findings from Clinical Risk Prediction and Trials Any Key Messages for Safety Pharmacology?
(2017)Anti-arrhythmic drugs are a mainstay in the management of symptoms related to arrhythmias, and are adjuncts in prevention and treatment of life-threatening ventricular arrhythmias. However, they also have the potential for ... -
Head and neck cancer surgery during the COVID-19 pandemic: An international, multicenter, observational cohort study.
(Wiley Periodicals LLC on behalf of American Cancer Society, 2021-07-15)BACKGROUND: The aims of this study were to provide data on the safety of head and neck cancer surgery currently being undertaken during the coronavirus disease 2019 (COVID-19) pandemic. METHODS: This international, ... -
Health data science course for clinicians: Time to bridge the skills gap?
(SAGE Publications, 2024-10-11)Background: Data science skills are highly relevant for clinicians working in an era of big data in healthcare. However, these skills are not routinely taught, representing a growing unmet educational need. This education ... -
Health Economics, Economic Evaluation and Artificial Intelligence Technology
Health economics is the study of allocating scarce goods within a healthcare market. Due to constrained budgets, clinical effectiveness is not enough to inform healthcare planning and provision. Economic evaluation enables ... -
Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection.
(2023-11)The present review summarizes the beneficial and detrimental roles of reactive oxygen species in myocardial ischemia/reperfusion injury and cardioprotection. In the first part, the continued need for cardioprotection beyond ... -
Health-related quality of life and healthcare costs of symptoms and cardiovascular disease events in patients with atrial fibrillation: a longitudinal analysis of 27 countries from the EURObservational Research Programme on Atrial Fibrillation general long-term registry.
(2024-06-03)AIMS: We examine the effects of symptoms and cardiovascular disease (CVD) events on health-related quality of life (HRQOL) and healthcare costs in a European population with atrial fibrillation (AF). METHODS AND RESULTS: ... -
Health-related quality of life in cardiac sarcoidosis: a systematic review.
(2023-03)People living with cardiac sarcoidosis (CS) are likely to have worse clinical outcomes and greater impairment on health-related quality of life (HRQoL) than other sarcoidosis manifestations. CS can result in a constellation ... -
Healthcare utilisation of 282,080 individuals with long COVID over two years: a multiple matched control, longitudinal cohort analysis.
(SAGE Publications, 2024-11-27)OBJECTIVES: To investigate healthcare utilisation and cost in individuals with long COVID (LC) at population level. DESIGN: Case-control cohort analysis with multiple age-, sex-, ethnicity-, deprivation-, region- and ... -
Heart Failure Following Anti-Inflammatory Medications in Patients With Type 2 Diabetes Mellitus
(Elsevier, 2023-04-10)